Galectin Therapeutics (GALT) Non-Current Assets (2010 - 2026)
Galectin Therapeutics' Non-Current Assets came in at $167,000 for Q2 2026, down 4.6% from $175,000 a year earlier but up 145.6% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Galectin Therapeutics' Non-Current Assets was $96,000, down 60.5% from FY2024.
- Non-Current Assets has declined in each of the last three years, with a five-year compound annual growth rate of -6.6% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $243,000 in FY2024 (-50.4%), $490,000 in FY2023 (-33.2%), $733,000 in FY2022 and $7,000 in FY2021 (-94.8%).
- The five-year range for quarterly Non-Current Assets is $7,000 (Q4 2021) to $793,000 (Q3 2022).
- Year-over-year, Non-Current Assets has declined for 12 consecutive quarters, with an average decline of 47.9% over the last eight quarters.
- The fastest year-over-year change in Non-Current Assets over five years came in Q1 2023 (growth of 523.1%), and the weakest in Q4 2021 (a decline of 94.8%).
- Business Quant data shows GALT's Non-Current Assets at $68,000 (Q1 2026), $96,000 (Q4 2025) and $136,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Galectin Therapeutics | 222.99 Mn | 166.33 Mn | - | 167,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 167,000.00 |
| Mar 31, 2026 | 68,000.00 |
| Dec 31, 2025 | 96,000.00 |
| Sep 30, 2025 | 136,000.00 |
| Jun 30, 2025 | 175,000.00 |
| Mar 31, 2025 | 243,000.00 |
| Dec 31, 2024 | 243,000.00 |
| Sep 30, 2024 | 306,000.00 |
| Jun 30, 2024 | 368,000.00 |
| Mar 31, 2024 | 430,000.00 |
| Dec 31, 2023 | 490,000.00 |
| Sep 30, 2023 | 552,000.00 |
| Jun 30, 2023 | 613,000.00 |
| Mar 31, 2023 | 673,000.00 |
| Dec 31, 2022 | 733,000.00 |
| Sep 30, 2022 | 793,000.00 |
| Jun 30, 2022 | 101,000.00 |
| Mar 31, 2022 | 108,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 40,000.00 |
API Access
Galectin Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();